Medical Device News Magazine

Christopher Bradbury Appointed CEO of Integrated Home Care Services

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Christopher Bradbury succeeds Jorge Pereda, Co-Founder, who held the role since IHCS‘ inception and will now assume a new role as Chairman of the Board. Bradbury’s appointment becomes effective August 15. Mr. Pereda will now assume a new role as Chairman of the Board.

The announcement comes as IHCS has achieved continued expansion as a result of the company’s record-setting growth. Founded in 2015, IHCS currently serves the home care needs of more than 2.2 million patients through partnerships with health plans and risk bearing provider organizations across the nation. The company anticipates serving more than 3 million patient lives under a value-based model by the end of 2023.

“After building successful companies throughout the last 30 years, I am excited to use my experience in a fully strategic capacity within IHCS,” said Jorge Pereda, outgoing CEO. “For nearly a year, we had been searching for a dynamic leader to pass the CEO baton to and I could not be happier that we found Chris. His experience and proven track record of delivering better outcomes for patients, providers, and health plans will further position IHCS to take that next step forward and unlock our potential to serve customers on a national level.”

With a background in accelerating growth for companies, Christopher Bradbury has a deep understanding of insurance, specialty pharmacy, population health, HIT, and other health service industries. Prior to joining IHCS, he served as a senior vice president at CVS Health, where he led Aetna’s commercial solutions and multi-billion dollar portfolio of specialty businesses. He also previously served as president of Aetna’s North Atlantic territory, including commercial and Medicare.

Bradbury’s other former roles include serving as President of Cigna’s pharmacy benefit management and specialty pharmacy businesses, and in executive positions at Medco Health Solutions, which was acquired by Express Scripts, and as a management consultant at A.T. Kearney.

Bradbury earned his MBA from the Sloan School of Management at MIT and received Bachelor of Science degrees in finance and international marketing from Georgetown University. Throughout his career, he has served on several boards, including the Specialty Pharmaceutical Care Management Board and the advisory board of CareAllies, Inc.

“I’ve seen the impact and importance of high-quality home care firsthand with my own family. That’s why IHCS’ track record of delivering on its promise of enhanced outcomes and lower costs through its integrated, value-based home care model has resonated with me,” said Christopher Bradbury. “IHCS’ approach has helped health plans enhance their home care services by improving clinical outcomes, lowering medical costs, enabling more actionable data insights, and accelerating their strategies to make healthcare easier. I’m excited to bring these benefits to more plans and patients across the country.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”